STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
crypto partnership acquisition

Silo Pharma (Nasdaq: SILO), a developmental-stage biopharmaceutical and cryptocurrency treasury company, has partnered with Fireblocks as its institutional crypto treasury platform custodian. The strategic agreement aims to enhance Silo's digital asset management capabilities for Bitcoin, Ethereum, and Solana.

Fireblocks, which has facilitated over $6 trillion in secure transfers, will provide enterprise-grade security through its multi-layer framework, combining multi-party computation technology, Intel SGX, and deposit address authentication. This infrastructure will support Silo's long-term strategy for buying, staking, trading, and managing digital assets.

Loading...
Loading translation...

Positive

  • Partnership with Fireblocks, a proven platform that has processed over $6 trillion in transfers
  • Access to institutional-grade security infrastructure for crypto asset management
  • Expansion into cryptocurrency treasury management with focus on Bitcoin, Ethereum, and Solana

Negative

  • Potential exposure to cryptocurrency market volatility
  • Deviation from traditional pharmaceutical business model into crypto assets may increase company risk profile

News Market Reaction 18 Alerts

+4.08% News Effect
+53.0% Peak Tracked
-14.2% Trough Tracked
+$302K Valuation Impact
$8M Market Cap
34.7x Rel. Volume

On the day this news was published, SILO gained 4.08%, reflecting a moderate positive market reaction. Argus tracked a peak move of +53.0% during that session. Argus tracked a trough of -14.2% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $302K to the company's valuation, bringing the market cap to $8M at that time. Trading volume was exceptionally heavy at 34.7x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy

SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has engaged Fireblocks, an enterprise platform for building blockchain applications and managing digital asset operations, as custodian for its institutional crypto treasury platform.

“Our engagement with Fireblocks is expected to ensure that our newly deployed crypto treasury platform is built with enterprise grade security and governance standards,” said Silo CEO Eric Weisblum. “We believe that Fireblocks’ proven institutional-grade infrastructure makes them the right partner to support our long-term strategy for buying, staking, trading, and managing our digital assets as we seek to build long-term value for our shareholders.”

Fireblocks is a globally recognized platform in the digital assets space, having facilitated the secure transfer of more than $6 trillion to date. Its multi-layer security framework combines multi-party computation (MPC) technology, Intel SGX, a signature policy engine, and a deposit address authentication network—delivering one of the most trusted custody solutions available to institutional clients.

“Partnering with Silo reflects our commitment to delivering secure, institutional-grade infrastructure that enables long-term value creation in digital assets,” said Ezra Solomon, Senior Manager of Corporate Strategy at Fireblocks. “We’re pleased to support their Bitcoin, Ethereum, and Solana treasury strategy with the technology and safeguards needed to buy, stake, and manage assets at scale.”

About Silo Pharma
Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. Its therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories. silopharma.com

About Fireblocks 
Fireblocks is an easy-to-use platform to create new blockchain-based products and manage day-to-day digital asset operations. Exchanges, banks, PSPs, lending desks, custodians, trading desks, and hedge funds can securely scale their digital asset operations through the Fireblocks Network and MPC-based Wallet Infrastructure. Fireblocks serves thousands of organizations in the financial, payments, and web3 space, has secured the transfer of over $6 trillion in digital assets and has a unique insurance policy that covers assets in storage and transit. Find out more at www.fireblocks.com 

Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified using words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential”, and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that could cause the actual results of Silo Pharma, Inc. (“Silo” or “the Company”) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this press release, whether as a result of new information, future events, or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events except as required by law.

Contact
800-705-0120
investors@silopharma.com


FAQ

What is the purpose of Silo Pharma's partnership with Fireblocks?

Silo Pharma has engaged Fireblocks to serve as custodian for its institutional crypto treasury platform, providing enterprise-grade security and governance standards for managing digital assets including Bitcoin, Ethereum, and Solana.

How much transaction value has Fireblocks processed to date?

Fireblocks has facilitated the secure transfer of more than $6 trillion in digital assets to date.

What cryptocurrencies will Silo Pharma manage through the Fireblocks platform?

Silo Pharma will manage Bitcoin, Ethereum, and Solana through the Fireblocks platform as part of its treasury strategy.

What security features does Fireblocks offer to Silo Pharma?

Fireblocks provides a multi-layer security framework that includes multi-party computation (MPC) technology, Intel SGX, a signature policy engine, and a deposit address authentication network.

How does this partnership affect Silo Pharma's business model?

This partnership expands Silo Pharma's business model beyond biopharmaceuticals to include cryptocurrency treasury management, aiming to build long-term value for shareholders through digital asset operations.
Silo Pharma Inc

NASDAQ:SILO

SILO Rankings

SILO Latest News

SILO Latest SEC Filings

SILO Stock Data

5.84M
11.45M
2.18%
4.3%
2.45%
Biotechnology
Pharmaceutical Preparations
Link
United States
SARASOTA